Insulet Corp at Piper Sandler Diabetes Day (Virtual) Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Piper Sandler Virtual Diabetes Day with Insulet Corporation. (Operator Instructions)
It is now my pleasure to turn the call over to Matt O'Brien to begin. Please go ahead, sir.
' -
All right. Thank you, Maria. Good morning, everybody. Thanks so much for joining us today on our Virtual Diabetes Investor Day. This is Matt O'Brien from Piper Sandler's MedTech research team. We are extremely pleased to have Insulet leading us off here today. From the company is Wayde McMillan, the Executive Vice President, CFO and Treasurer; Bret Christensen, Executive Vice President and Chief Commercial Officer; and then Deb Gordon, Vice President of IR. This is a webinar, so we cannot get questions telephonically from the audience. (Operator Instructions)
With that preamble out of the way, let's go ahead and get started. Wayde, Bret and Deb, thank you so much for joining us this
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |